Atossa Genetics Inc. (ATOS) Social Stream
ATOSSA THERAPEUTICS INC (ATOS) Price Targets From Analysts
Use the tables below to see what analysts covering ATOSSA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-25 | 1 | $7 | $7 | $7 | $0.91 | 669.23% |
| 2022-04-08 | 1 | $4 | $4 | $4 | $0.91 | 339.56% |
| 2023-09-08 | 2 | $5 | $5 | $5 | $0.91 | 449.45% |
| 2023-10-20 | 1 | $4.001 | $4.001 | $4.001 | $0.91 | 339.67% |
| NA | 1 | $NA | $NA | $NA | $0.91 | NA% |
Price Target Last Issued NA NA, NA
The Trend in the Analyst Price Target
Over the past 33 months, ATOS's average price target has gone down $2.25.
ATOS reports an average of 529.18% for its upside potential over the past 42 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-09-08 | 1 | 5.000 | 5.000 | 5.000 | 0.834 | 499.52% |
| 2023-09-08 | 2 | 5.000 | 5.000 | 5.000 | 0.834 | 499.52% |
| 2023-10-20 | 2 | 4.001 | 4.001 | 4.001 | 0.660 | 506.21% |
| 2023-10-20 | 2 | 5.000 | 4.001 | 4.500 | 0.660 | 581.82% |
| 2023-10-20 | 1 | 4.001 | 4.001 | 4.001 | 0.660 | 506.21% |
ATOS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 24 months, ATOS's average broker recommendation rating improved by 1.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how ATOSSA THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 8.49% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ATOSSA THERAPEUTICS INC's variance in analysts' estimates is lower than 89.5% of them.
- ATOS has a greater average analyst price target than 43.97% of Healthcare stocks.
- In the context of stocks in the small market cap category, ATOSSA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 561.77% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ATOSSA THERAPEUTICS INC are NHWK, TNXP, and ACRX.
View All Top Stocks by Price Target
Is ATOS a Buy, Hold or Sell? See the POWR Ratings now!